Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food Allergy Clinical Study

Press/Media

Period	1 Jul 2019

Media coverage

Title	Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food Allergy Clinical Study
Media name/outlet	BioSpace
Country/Territory	United States
Date	1/07/19
URL	https://www.biospace.com/article/releases/vedanta-biosciences-announces-first-patient-enrolled-in-ve416-phase-1b-2-food-allergy-clinical-study/
Persons	Jeremiah Faith